Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Research & Development In Brief

This article was originally published in The Tan Sheet

Executive Summary

B vitamins may lower depression: Older adults' total intakes of vitamins B6 and B12 protect against depressive symptoms over time, according to a longitudinal study conducted by researchers including Kimberly Skarupski, Rush Institute for Healthy Aging, Rush University Medical Center, Chicago. Supported by a grant from the National Institutes of Health, the research was published in the June 2 issue of the American Journal of Clinical Nutrition. The study of 3,503 adults from the ongoing Chicago Health and Aging project with adults ages 65 and older found higher total intakes of the vitamins were associated with a decreased likelihood of depression, after adjusting for factors including age, sex, race and antidepressant medication use. Each additional 10 mg of vitamin B6 and additional 10 mcg of vitamin B12 were associated with "2 percent lower odds of depressive symptoms per year," according to researchers

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

ID1131849

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel